Veterinary Drugs Compounding Market, By Drug Class (CNS Agents, Anti-infective Agents, Hormones and Substitutes, Anti-inflammatory Agents, Others), By Animal Type (Companion Animals and Livestock Animals), By Formulation (Oral, Injectable, Others), By Geo
Veterinary Drugs Compounding Market, By Drug Class (CNS Agents, Anti-infective Agents, Hormones and Substitutes, Anti-inflammatory Agents, Others), By Animal Type (Companion Animals and Livestock Animals), By Formulation (Oral, Injectable, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Compounded medications play an important role in veterinary medicine by allowing for customized medication preparations tailored to individual animal patients' needs. These are most commonly used when an FDA-approved drug may not exist in the appropriate strength or dosage form required for a patient. Compounded drugs allow veterinarians to create customized medications and doses depending on factors like pet's size, age, or medical condition. This flexible approach to medication can help improve treatment outcomes for many animals.
Market Dynamics:
Global veterinary drugs compounding market growth is driven by factors such as rising pet ownership and increased spending on pet care over the past few years. Growing awareness among pet owners about providing customized medical care to their animals can drive the market growth. However, lack of regulation and quality standards for compounded drugs poses safety risks and can hamper the market growth. Advantages like flexibility in dosages and forms for compounded drugs present lucrative opportunities for market players. Recent FDA guidelines to strengthen quality oversight of these facilities could drive the market growth.
Key features of the study:
This report provides in-depth analysis of the global veterinary drugs compounding market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global veterinary drugs compounding market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Patterson Veterinary, Chase Pharmaceuticals, Kentucky Performance Products, Animal Medics and Rx3 Compounding
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global veterinary drugs compounding market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary drugs compounding market.
Detailed Segmentation-
By Drug Class
CNS Agents
Anti-infective Agents
Hormones and Substitutes
Anti-inflammatory Agents
Others
By Animal Type
Companion Animals
Dogs
Cat
Others
Livestock Animals
By Formulation
Oral
Injectable
Others
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profiles:
Wedgewood Pharmacy
Diamondback Drugs LL
Stokes Pharmacy
MEDISCA
Patterson Companies, Inc.
Boehringer Ingelheim
Zoetis Inc.
Covetrus
Virbac
Dechra Pharmaceuticals PLC
Elanco
Kindred Biosciences, Inc.
Merck & Co., Inc.
Bayer AG
Putney, Inc.
Norbrook Laboratories Limited
Vetoquinol S.A.
Ceva Santé Animale
Rood and Riddle Veterinary Pharmacy
Mwi Veterinary Supply Co.
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Drug Class
Market Snapshot, By Animal Type
Market Snapshot, By Formulation
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter’s Analysis
4. Global Veterinary Drugs Compounding Market - Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the Market
5. Global Veterinary Drugs Compounding Market, By Drug Class, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
CNS Agents
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Anti-infective Agents
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Hormones and Substitutes
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Anti-inflammatory Agents
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
6. Global Veterinary Drugs Compounding Market, By Animal Type, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Companion Animals
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Dogs
Cat
Others
Livestock Animals
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
7. Global Veterinary Drugs Compounding Market, By Formulation, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Oral
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Injectable
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
8. Global Veterinary Drugs Compounding Market, By Region, 2019 – 2031, (USD Bn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2019–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Company Profiles
Wedgewood Pharmacy
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Diamondback Drugs LL
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Stokes Pharmacy
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
MEDISCA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Patterson Companies, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Boehringer Ingelheim
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Zoetis Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Covetrus
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Virbac
Dechra Pharmaceuticals PLC
Elanco
Kindred Biosciences, Inc.
Merck & Co., Inc.
Bayer AG
Putney, Inc.
Norbrook Laboratories Limited
Vetoquinol S.A.
Ceva Santé Animale
Rood and Riddle Veterinary Pharmacy
Mwi Veterinary Supply Co.
10. Analyst Recommendation
Wheel of Fortune
Analyst View
Coherent Opportunity Map
11. References and Research Methodology
References
Research Methodology
About Us and Sales Contact
*Browse 32 market data tables and 28 figures on Veterinary Drugs Compounding Market” - Global forecast to 2031